Buprenorphin Mylan 7 Tage 20 Mikrogramm/Stunde transdermales Pflaster
Country: Germany
Language: German
Source: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Buprenorphin
Available from:
Allomedic GmbH (8118422)
Dosage:
20 Mikrogramm/Stunde
Pharmaceutical form:
transdermales Pflaster
Composition:
Teil 1 - transdermales Pflaster; Buprenorphin (20180) 20 Milligramm
Administration route:
transdermale Anwendung
Authorization status:
zugelassen
Authorization date:
2021-12-21
